Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Saccharomyces Cerevisiae
100%
Clinical Treatment
100%
Clinical Aspects
100%
Epidemiology
100%
Vaginitis
100%
Nonspecific Vaginitis
50%
Candida Albicans (C. albicans)
16%
Clinical Response
16%
Fluconazole
16%
Predisposing Factors
16%
In Vitro Test
16%
Prolonged Therapy
16%
Electrophoretic Karyotyping
16%
Longitudinal Follow-up
16%
Vaginal Isolates
16%
Reduced Susceptibility
16%
Torulopsis Glabrata
16%
Saccharomyces Species
16%
Vaginal Infections
16%
Vaginal Colonization
16%
Vaginal Pathogens
16%
Antimycotic
16%
Epidemiological Relationship
16%
Antimycotic Drugs
16%
Reinfection
16%
Azole Agents
16%
Symptomatic Patients
16%
Extremely Rare
16%
Immunology and Microbiology
Saccharomyces cerevisiae
100%
Vaginitis
100%
Cohort Effect
100%
Saccharomyces cerevisiae
66%
Infectious Agent
16%
Candida Albicans
16%
Budding Yeast
16%
Karyotyping
16%
Candida Glabrata
16%
Vagina
16%
In Vitro
16%
Susceptibility
16%
Medicine and Dentistry
Clinical Feature
100%
Vaginitis
100%
Epidemiology
100%
Antifungal Agent
33%
In Vitro
16%
Fluconazole
16%
Disease Predisposition
16%
Pathogen
16%
Reinfection
16%
Oral
16%
Pyrrole
16%